Shukra Pharmaceuticals Ltd share price logo

Shukra Pharma Share Price

BSE: 524632

Small Cap

Healthcare Sector

₹41.34

+1.26

(+3.14%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Shukra Pharma Stock Performance

as on February 27, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹38.20
    ₹41.50
    downward going graph

    7.60%

    Downside

    0.39%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹11.74
    ₹65.26
    downward going graph

    71.60%

    Downside

    57.86%

    Upside

    downward going graph

Shukra Pharma share price movements today

Previous Close
₹40.08
Open
₹40.98
Volume
2.78L
Upper Circuit
₹42.08
Lower Circuit
₹38.08
Day's Low - High
₹38.20 - ₹41.50
52 Week Low - High
₹11.74 - ₹65.26

Shukra Pharma Historical Returns

1 Month Return
+ 1.53 %
3 Month Return
+ 6.62 %
1 Year Return
+ 75.49 %
3 Year Return
+ 3147.24 %
5 Year Return
+ 18645.45 %

Shukra Pharma Fundamentals

as on February 27, 2026 at 4:01 pm IST

Market Cap

₹1,805.81 Cr

Return on Equity (ROE)

15.9

PE Ratio (TTM)

62.48

Return on capital employed (ROCE)

21.76

Industry PE ratio

42.7

Beta (LTM)

-0.15

P/B Ratio

15.17

Dividend Yield

0

PEG Ratio

106.27

Quarterly Earnings Growth YOY

544.3

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bullish

View Technical Analysis

Shukra Pharma Stock Valuation

as on February 27, 2026 at 4:01 pm IST

Shukra Pharma in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 26, 2025

Industry (42.70x)

February 27, 2026

Today (62.48x)

February 27, 2026

Highest (238.00x)

December 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 62.48x

Shukra Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Shukra Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Shukra Pharmaceuticals Ltd image
Shukra Pharmaceuticals Ltd
NA1,805.813729.09%0.00932
Concord Drugs Ltd image
Concord Drugs Ltd
NA79.0041.84%0.70145
Gennex Laboratories Ltd image
Gennex Laboratories Ltd
NA273.0734.3%0.5818137
OneSource Specialty Pharma Ltd image
OneSource Specialty Pharma Ltd
BUY15,437.18-4.25%0.57-181,444
Piramal Pharma Ltd image
Piramal Pharma Ltd
BUY20,753.55-3.57%0.69919,151
See all

Shukra Pharma Stock’s Investor Sentiment and Interest

Investment in Shukra Pharmaceuticals Ltd Shares on INDmoney has dropped by -50.26% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-50.26% versus previous 30 day period

Search interest for Shukra Pharmaceuticals Ltd Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-19% versus previous 30 day period

Shukra Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
10.58
13.27
5.39
5.88
39.13
Other Income
1.01
1.47
1.11
1.71
0.82
Total Income
11.59
14.74
6.5
7.59
39.95
Expenses
6.65
5.95
4.07
6.3
12
Operating Profit
3.93
7.32
1.32
-0.42
27.13
Operating Profit Margin %
37.15%
55.16%
24.49%
-7.14%
69.33%
Profit Before Interest, Tax and Depreciation
4.94
8.78
2.43
1.29
27.95
Interest
0.15
0.27
0.27
0.29
0.28
Depreciation
0.7
0.94
0.79
0.81
0.84
Profit Before Tax
4.09
7.57
1.37
0.19
26.83
Tax Paid
0.93
2.18
0.35
-2.18
6.46
Profit After Tax
3.16
5.39
1.03
2.38
20.36
Total Net profit including share of profit / Loss from associate company
3.16
5.39
1.03
2.38
20.36
EPS
0.72
0.12
0.02
0.05
0.47
Actual EPS
0.72
0.12
0.02
0.05
0.47
Adjusted EPS
0.07
0.12
0.02
0.05
0.47
Diluted EPS
0.72
-
-
0.05
0.47

Shukra Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2025
Sales
32.59
Other Income
4.21
Total Income
36.79
Expenses
19.86
Operating Profit
12.73
Operating Profit Margin %
39.06%
Profit Before Interest, Tax and Depreciation
16.94
Interest
0.59
Depreciation
3
Profit Before Tax
13.35
Tax Paid
3.76
Profit After Tax
9.58
Total Net profit including share of profit / Loss from associate company
9.58
EPS
0.22
Actual EPS
0.22
Adjusted EPS
0.22
Diluted EPS
0.22

Shukra Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
2.72
-0.29
0.84
0.26
1.24
0.54
7.99
3.17
-5.2
7.92
Cash Flow from Investing Activities
-0.41
-0.93
-4.75
-2.45
-3.35
-1.88
-1.53
-4.43
-1.2
-1.26
Cash Flow from Financing Activities
-1.16
-
3.46
2.38
1.99
1.74
-6.67
4.94
12.4
-4.51
Net Cash Flow
1.15
-1.22
-0.46
0.18
-0.12
0.38
-0.21
3.68
6.01
2.14

Shukra Pharma Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Aug 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
50.9%
50.9%
50.9%
50.9%
50.96%
50.96%
50.96%
50.96%
50.96%
50.96%
50.96%
50.96%
50.96%
DII
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
0.11%
Public
48.99%
48.99%
48.99%
48.99%
48.93%
48.93%
48.93%
48.93%
48.93%
48.93%
48.93%
48.93%
48.93%
Total Outstanding Shares
1,09,59,725
1,09,59,725
1,09,59,725
1,09,59,725
1,09,46,986
1,09,46,986
4,37,87,944
4,37,87,944
4,37,87,944
43,78,79,440
43,78,79,440
43,78,79,440
43,78,79,440
Total Shareholders
9,531
9,582
9,600
9,747
10,963
12,974
14,989
16,321
17,844
18,231
20,337
21,441
25,649

Shukra Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Shukra Pharma .

  • Shukra Pharmaceuticals Ltd Earnings Results

    Shukra Pharmaceuticals Ltd’s net profit jumped 544.3% since last year same period to ₹20.36Cr in the Q3 2025-2026. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated 755.46% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Shukra Pharmaceuticals Ltd Dividends June,2025

    In the quarter ending March 2025, Shukra Pharmaceuticals Ltd has declared dividend of ₹0.01 per share on 04 Jun 2025 - translating a dividend yield of 0.02%.

    Read More about Dividends

Insights on Shukra Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, Shukra Pharma. stock has moved up by 2891.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.96% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 48.93% of holdings in Dec 2025 quarter

About Shukra Pharmaceuticals Ltd

Shukra Pharmaceuticals Ltd Formerly known Relish Pharmaceuticals Limited was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September 2016. The Company is presently engaged in the business of manufacturing of pharmaceuticals Products and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics Penicillin Anti Biotics Cephalosporin Anti Biotics Macrolides Quinolones Anti Bacterial Anti Fungal Anti Malarial Anti Viral Anti Protozoal Anti Anthelmintic Sedative and Tranquilliser Anti Depressant Anti Manic Anti Emetic Anti Ulcer Beta Blockers Diuretics Analgesic Analgesic NASID Muscle Relaxants Anti Tuberculosis Vitamin Products Anti Allergics Corticosteroids Hyper and Hypoglycemic Others.The company has four manufacturing divisions namely tablets General and Beta Lactum Capsules General and Beta Lactum Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat.The company customers include leading Manufacturers like Cadila Healthcare Limited Zydus Intas Pharmaceuticals Limited Cadila Pharmaceuticals Limited Makers Laboratories Limited Agenta Pharma Limited etc.The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world.In FY 201314 the Company got approval from Honble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited Transferor Company with Relish Pharmaceuticals Limited Transferee Company and Reorganization of Share Capital of Relish Pharmaceuticals Limited Transferee Company through Scheme of Arrangement vide Honble High Court of Gujarat order dated 20 Dec 2013..

Revenue: ₹39.13Cr as on December 2025 (Q3 FY26)
Net Profit: ₹20.36Cr as on December 2025 (Q3 FY26)
Chairperson Name: Dakshesh Shah
OrganisationShukra Pharmaceuticals Ltd
IndustryPharmaceuticals
CEODakshesh Shah
E-voting on sharesClick here to vote

FAQs

What is Shukra Pharma share price today?

Shukra Pharma share price today stands at ₹41.34 as on at the close of the market. Shukra Pharma share today touched a day high of ₹41.5 and a low of ₹38.2.

What is the 52 week high and 52 week low range for Shukra Pharma share?

Shukra Pharma touched a 52 week high of ₹65.26 and a 52 week low of ₹11.74. Shukra Pharma share price today i.e. is closed at ₹41.34, which is -36.65% down from its 52 week high and 252.13% up from its 52 week low.

What is Shukra Pharma 's market capitalisation today?

Shukra Pharma market capitalisation is ₹1,805.81 Cr as on .

How to buy Shukra Pharma shares?

To buy Shukra Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524632 or Shukra Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Shukra Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Shukra Pharma trading volume today?

Shukra Pharma trading volume is 2.78L as on . This means that 2.78L shares of Shukra Pharma were bought and sold on the stock market during today's trading session.